McKesson Divisions Breakdown
U.S. Pharmaceutical
U.S. Pharmaceutical is a reportable segment that distributes branded, generic, specialty, biosimilar,
and over-the counter pharmaceutical drugs and other healthcare-related products in the United States
(“U.S.”). This segment also provides practice management, technology, clinical support, and business
solutions to community-based oncology and other specialty practices. In addition, the segment sells
financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate sites) and provides
consulting, outsourcing, technological, and other services.
©2025 RXinsider | RXinsider Market Intelligence Group | 2025
McKesson operates its business in four reportable segments:
U.S. Pharmaceutical, Prescription Technology Solutions (“RxTS”),
Medical-Surgical Solutions, and International.
Prescription Technology Solutions
(RxTS)
Prescription Technology Solutions (RxTS) is a reportable segment that combines automation and
McKesson’s ability to navigate the healthcare ecosystem to connect patients, pharmacies, providers,
pharmacy benefit managers, health plans, and biopharma to address patients’ medication access,
affordability, and adherence challenges. RxTS also offers prescription price transparency, benefit
insight, dispensing support services, as well as third-party logistics and wholesale distribution support
across various therapeutic categories and temperature ranges to biopharma customers throughout
the product lifecycle.
Medical-Surgical Solutions
Medical-Surgical Solutions is a reportable segment that provides medical-surgical supply distribution,
logistics, and other services to healthcare providers, including physician offices, surgery centers,
nursing homes, hospital reference labs, and home health care agencies. This segment offers national
brand medical-surgical products as well as McKesson’s own line of high-quality products through a
network of distribution centers within the U.S.
International
International is a reportable segment that includes our operations in Canada and Europe, bringing
together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care
services. McKesson’s Canadian operations deliver medicines, supplies, and information technology
solutions throughout Canada and includes Rexall Health retail pharmacies. During fiscal 2023,
McKesson completed transactions to sell certain of our businesses in the European Union (“E.U.
disposal group”), and their retail and distribution businesses in the United Kingdom (“U.K. disposal
group”). McKesson’s remaining operations in Europe provide distribution and services to wholesale
and retail customers in Norway where they own, partner, or franchise with retail pharmacies.